Impact of the amended CIR 520/2012 to UK authorised products

Posted by: , Posted on: - Categories: Good pharmacovigilance practice, GPvP, Pharmacovigilance

From 12 February 2026, amendments to the EU Commission Implementing Regulation (CIR) 520/2012 come into effect. While the UK operates an independent regulatory system, these changes have practical implications for some UK-authorised products, particularly in relation to pharmacovigilance (PV) requirements. …